Tesamorelin- Egrifta -Metabolic disorder (Nov 2010)
Drug Name:
Tesamorelin- Egrifta -Metabolic disorder (Nov 2010)
List Of Brands:
Indication Type Description:
Indication:
Proprietary Name- Egrifta
Established Name - Tesamorelin
Applicant- Theratechnologies
Indication-
Indication for reduction of excess abdominal fat in HIV-infected patients
with Lipodytrophy
Approved by FDA on 10-11-2010 (Ref- FDA approved List- 2010)
Dosages/ Overdosage Etc:
Indication-
Indication for reduction of excess abdominal fat in HIV-infected patients
with Lipodytrophy